Total investments received (USD): N/A
Round value (USD): N/A
Company: Avexxin
Industry:
Health services
Pharma




Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Iceland
Latvia
Lithuania
France
Ireland
Italy
Portugal
Spain